Advocacy Collaboration Strong government engagement and a track record of securing federal recognition and funding from NIH and the Department of Defense create partnership opportunities with funders, research institutions, and policy groups seeking patient-centric advocacy and translational research.

Research Partnerships Active collaborations through the iCureCeliac patient registry and partnerships with pharmaceutical companies (examples include Takeda) indicate demand for standardized data collection, real-world evidence, and symptom diary validation to accelerate clinical trials and product development.

Education & Outreach Recent initiatives to support students, colleges, and healthcare professionals signal opportunities to offer educational programs, certification tools, and onboarding resources to schools, universities, and clinics seeking Celiac-aware curricula and patient support.

Fundraising Platform The organization operates at a mid-to-large scale with substantial revenue, suggesting capacity to co-sponsor research initiatives, donor programs, and cause-marketing campaigns with corporate partners, nonprofits, and health brands looking for alignment with autoimmune disease initiatives.

Digital & Data Assets Tech stack and a data-driven focus imply potential for B2B data collaborations, sponsor-branded registries, and digital health solutions, including metrics, dashboards, and patient-reported outcomes data to support trial design and regulatory submissions.